Glycolytic activity following anti‐<scp>CD19 CAR</scp>‐T cell infusion in non‐Hodgkin lymphomaNicolas Vallet(Université de Tours), Emmanuel Gyan(Inserm)European Journal of Clinical InvestigationNovember 1, 202410.1111/eci.14342Cited by 0SaveCiteExport RISWatch citationsRelated PapersEpcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study|The Lancet Haematology|2024|134Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion Cohort|Blood|2023|38